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Abstract
Clostridium difﬁcile infections (CDIs) are a common cause of antibiotic-associated diarrhoea and associated with CDI-related mortality in c.
10%. To date, there is no prediction model in use that guides clinicians to identify patients at high risk for complicated CDI. From 2006 to
2009, nine Dutch hospitals included hospitalized CDI patients in a prospective cohort. Potential predictors of a complicated course (ICU
admission, colectomy or death due to CDI) were evaluated in uni- and multivariate logistic regression. A score was constructed that was
internally validated by bootstrapping. Furthermore, a pilot external validation was performed. Twelve per cent of 395 CDI patients had a
complicated course within 30 days after diagnosis. Age (≥85 years, OR 4.96; 50–84 years, 1.83), admission due to diarrhoea (OR 3.27),
diagnosis at the ICU department (OR 7.03), recent abdominal surgery (OR 0.23) and hypotension (OR 3.25) were independent predictors
of a complicated course. These variables were used to construct a prediction model. A score subsequently classiﬁed patients into high risk
(39% with a complicated course), intermediate (16%), low (5%) or virtually no risk of experiencing a complicated course. The score
performed well after internal validation (AUC 0.78) and a pilot external validation among 139 patients showed similar good performance
(AUC 0.73). We present an easy-to-use, clinically useful risk score that is capable of categorizing CDI patients according to their outcome.
Because classiﬁcation is available at diagnosis, it could have major implications for treatment choice.
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Abstract
Chronic osteomyelitis of the jaw (COMJ) is one of the most intractable diseases among head and neck infections. Antimicrobial agents are
routinely administered forCOMJwithout sufﬁcient bacterial information, resulting in frequent treatment failures. To improve our knowledge
of the bacterial aetiology of COMJ and to assist in the development of effective treatments, we performed a comprehensive analysis of the
microbiome. Sixteen patients with four clinical types of COMJ (four with suppurative osteomyelitis, three with osteoradionecrosis of the jaw,
four with primary chronic osteomyelitis, and ﬁve with bisphosphonate-related osteonecrosis of the jaw) were enrolled in this study. Bone
samples were subjected to bacterial community comparisons by 16S rRNA gene pyrosequencing. As a result, we clariﬁed that COMJ was
caused by a far greater range of bacterial species (12 phyla and 163 genera) than previously reported. Moreover, the bacterial structures in
COMJ changed dramatically with disease stage and the condition of the affected bone. Multiple correlation analyses revealed that
sequestration and bone exposure could affect the community structure.On the basis of these factors, we reclassiﬁedCOMJ into three clinical
stages: I, inﬂamed or sclerotic bonewithout exposure; II, sequestrumwithout exposure; and III, exposed sequestrum. In stage II, the bacterial
diversity was signiﬁcantly lower, and the anaerobe genera Fusobacterium, Tannerella (formerly Bacteroides) and Porphyromonas were more
abundant, than observed during other stages. Because these bacteria habitually reside in any clinical stage, they were considered to constitute
the core microbiome of COMJ. Targeting these bacteria should lead to the development of effective preventive measures and cures.
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Abstract
Previousworkhas suggested that central-line-associatedbloodstream infection (CLABSI) is associatedwith increased costs and riskofmortality;
however, no studies have looked at both total and variable costs, and information onoutcomes outside of the intensive-care unit (ICU) is sparse.
The aim of this study was to determine the excess in-hospital mortality and costs attributable to CLABSI in ICU and non-ICU patients. We
conducted a retrospective cohort and cost-of-illness study from the hospital perspective of 398 patients at a tertiary-care academic medical
centre from 1 January 2008 to 31December 2010. All CLABSI patients and a simple random sample drawn from a list of all central lines inserted
during the study periodwere included. Generalized linearmodels with log link and gamma distributionwere used tomodel costs as a function of
CLABSI and important covariates. Costs were adjusted to 2010 US dollars by use of the personal consumption expenditures for medical care
index. We used multivariable logistic regression to identify independent predictors of in-hospital mortality. Among both ICU and non-ICU
patients, adjusted variable costs for patientswithCLABSIwere c. $32 000 (2010USdollars) higheron average than for patientswithoutCLABSI.
Afterwecontrolled for severityof illness andotherhealthcare-associated infections,CLABSIwas associatedwitha2.27-fold (95% CI 1.15–4.46)
increased risk of mortality. Other healthcare-associated infections were also signiﬁcantly associated with greater costs and mortality. Overall,
CLABSIwas associatedwith signiﬁcantly higheradjusted in-hospitalmortality and total andvariablecosts than those forpatientswithoutCLABSI.
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